Filing Flows › Ginkgo Bioworks Holdings (DNA) › Stock forecast & fair value
Ginkgo Bioworks Holdings (DNA) stock forecast and price target
Ginkgo Bioworks Holdings (DNA) trades at $11.29. 2 analysts' median price target is $8.00 (-29%), from $5.00 to $11.00.
Ginkgo Bioworks Holdings' latest quarter
Ginkgo Bioworks Holdings, Q2 2026: revenue $20.2M (-48% year over year), operating margin -290.5%, net loss $46.7M, operating cash flow −$44.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DNA stock?
The median of 2 analysts' 12-month targets is $8.00, -29% from $11.29; the range is $5.00 to $11.00. The average rating is none.
Does Ginkgo Bioworks Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is DNA stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.